title: Intraocular Pressure rise after Anti-VEGF Treatment: Prevalence, Possible Mechanisms and Correlations.
abstract: Intraocular pressure (IOP) rise after anti-vascular endothelial growth factor (VEGF) treatment for neovascular age-related macular degeneration (AMD) can be either short-term or long-term and may require medical intervention. Short-term IOP spikes are a fairly common and well recognized complication of anti-VEGF injections. Long-term IOP rise is less well-understood and disputed as a complication by some authors. We try to review current literature on the subject and especially studies focused on the prevalence of this complication, speculate on possible mechanisms of IOP rise and discuss correlations of long-term IOP rise with the nature of the injected agent, average number of injections, previous glaucoma history and other factors. How to cite this article: Kampougeris G, Spyropoulos D, Mitropoulou A. Intraocular Pressure rise after Anti-VEGF Treatment: Prevalence, Possible Mechanisms and Correlations. J Current Glau Prac 2013;7(1):19-24.
authors.affiliation: Private Practice, Department of Ophthalmology, Greece.
authors.forename: George
authors.initials: G
authors.lastname: Kampougeris
authors.affiliation: Department of Ophthalmology, Athens Medical Center, Greece.
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Spyropoulos
authors.affiliation: Department of Ophthalmology, Athens Medical Center, Greece.
authors.forename: Adrianna
authors.initials: A
authors.lastname: Mitropoulou
keywords: Anti-VEGF injections; Intraocular pressure rise.; Neovascular AMD